Wy-14,643, a peroxisome proliferator, inhibits compensative cell proliferation and hepatocyte growth factor mRNA expression in the rat liver

Cancer Letters

Volumn 135, Issue 2, 1999, Pages 145-150

  Motoki, Yoshiteru ^a   Tamura, Hiroshi ^a   Watanabe, Takafumi ^a   Suga, Tetsuya ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Hepatocarcinogenesis; Hepatocyte growth factor; Non genotoxic carcinogen; Partial hepatectomy; Peroxisome proliferator; Wy 14,643

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR; PIRINIXIC ACID; SCATTER FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; DNA SYNTHESIS; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT;

ANIMALS; CARCINOGENS; CELL DIVISION; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; LIVER; MALE; PEROXISOME PROLIFERATORS; PYRIMIDINES; RATS; RATS, INBRED F344; RNA, MESSENGER; TIME FACTORS;

EID: 0033060843     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00287-0     Document Type: Article

References (29)

1. Reddy J.K., Azarnoff D.L., Hignite C.E. Hypolipidemic hepatic peroxisome proliferators from a novel class of chemical carcinogens. Nature. 283:1980;397-398.
2. Reddy J.K., Lalwani N.D. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol. 12:1983;1-58.
3. Kluwe W.M., Huff J.E., Matthews H.B., Irwin R., Haseman J.K. Comparative chronic toxicities and carcinogenic potential 2-ethylhexyl-containing compounds in rats and mice. Carcinogenesis. 6:1985;1577-1583.
4. Ishii H., Suga T. Clofibrate-like effects of acetylsalicylic acid on peroxisomes and on hepatic and serum triglyceride levels. Biochem. Pharmacol. 28:1979;2829-2833.
5. Horie S., Suga T. Enhancement of peroxisomal (-oxidation in the liver of rats and mice treated with valproic acid. Biochem. Pharmacol. 34:1985;1357-1362.
6. Motoki Y., Tamura H., Morita R., Watanabe T., Suga T. Decreased hepatocyte growth factor level by Wy-14,643. non-genotoxic hepatocarcinogen in F-344 rats. Carcinogenesis. 18:1997;1303-1309.
7. Nakamura T., Teramoto H., Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc. Natl. Acad. Sci. USA. 83:1986;6489-6493.
8. Nakamura T., Nawa K., Ichihara A., Kaise N., Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 224:1987;311-316.
9. Gohda E., Tsubouchi H., Nakayama H., Hirono S., Sakiyama O., Takahashi K., Miyazaki H., Hashimoto S., Daikuhara Y. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J. Clin. Invest. 81:1988;414-419.
10. Zarnegar R., Michalopoulos G. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res. 49:1989;3314-3320.
11. Zarnegar R., DeFrances M.C., Kost D.P., Lindroos P., Michalopoulos G. Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem. Biophys. Res. Commun. 177:1991;559-565.
12. Nakamura T., Nawa K., Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122:1984;1450-1459.
13. Naka D., Ishii T., Yoshiyama Y., Miyazawa K., Hara H., Hishida T., Kitamura N. Activation of hepatocyte growth factor by proteolytic conversion of a single form to a heterodimer. J. Biol. Chem. 267:1992;20114-20119.
14. Tajima H., Matsumoto K., Nakamura T. Hepatocyte growth factor has potent anti-proliferative activity in various tumor cells. FEBS Lett. 291:1991;229-232.
15. Shiota G., Rhoads D.B., Wang T.C., Nakamura T., Schmidt E.V. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc. Natl. Acad. Sci. USA. 89:1992;373-377.
16. Higgins G.M., Anderson R.M. Experimental pathology of the liver; restoration of the liver of the white rat following partial surgical removal. Arch. Pathol. 12:1931;186-202.
17. Eacho P.I., Lanier T.L., Brodhecker C.A. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883. Carcinogenesis. 12:1991;1557-1561.
18. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
19. Chohen S.M., Ellwein L.B. Cell proliferation in carcinogenesis. Science. 249:1990;972-975.
20. Kinoshita T., Tashiro K., Nakamura T. Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins. Biochem. Biophys. Res. Commun. 165:1989;1229-1234.
21. Noji S., Tashiro K., Koyama E., Nohno T., Ohyama K., Taniguchi S., Nakamura T. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem. Biophys. Res. Commun. 173:1990;42-47.
22. Matsumoto K., Tajima H., Okazaki H., Nakamura T. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-(1 and glucocorticoids. J. Biol. Chem. 267:1992;2491-24920.
23. Rumsby P.C., Davies M.J., Price R.J., Lake B.G. Effect of some peroxisome proliferators on transforming growth factor-(1 gene expression and insulin-like growth factor II/mannose-6-phosphate receptor gene expression in rat liver. Carcinogenesis. 15:1994;419-421.
24. Mullhaupt B., Faren A., Fodor E., Jones A. Liver expression of epidermal growth factor RNA. J. Biol. Chem. 269:1994;19667-19670.
25. Mead J.E., Fausto N. Transforming growth factor α may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc. Natl. Acad. Sci. USA. 86:1989;1558-1562.
26. Kiso S., Kawata S., Tamura S., Higashlyama S., Ito N., Tsushima H., Taniguchi N., Matsuzawa Y. Role of heparin-binding epidermal growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy. Hepatology. 22:1995;1584-1590.
27. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347:1990;645-650.
28. Tugwood J.D., Issemann I., Anderson R.G., Bundell K.R., McPheat W.L., Green S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′-flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11:1992;433-439.
29. Xinfang M.A., Stoffregen D.A., Wheelock G.D., Rininger J.A., Babish J.G. Discordant hepatic expression of the cell division control enzyme p34CdC2 kinase, proliferating cell nuclear antigen, p53 tumor suppressor protein, and p21Waf1, cyclin-dependent kinase inhibitory protein after Wy14,643 ([4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid) dosing to rats. Mol. Pharmacol. 52:1997;69-78.